Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges

Triple negative breast cancer (TNBC) is a highly heterogeneous disease with a poor prognosis and a paucity of therapeutic options. In recent years, immunotherapy has emerged as a new treatment option for patients with TNBC. However, this therapeutic evolution is paralleled by a growing need for biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoxiao, Collet, Laetitia, Rediti, Mattia, Debien, Véronique, De Caluwé, Alex, Venet, David, Romano, Emanuela, Rothé, Françoise, Sotiriou, Christos, Buisseret, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917763/
https://www.ncbi.nlm.nih.gov/pubmed/36769602
http://dx.doi.org/10.3390/jcm12030953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917763/
https://www.ncbi.nlm.nih.gov/pubmed/36769602
http://dx.doi.org/10.3390/jcm12030953

Ejemplares similares